Neuraxis, Inc. (NRXS) is a Healthcare · Biotechnology company listed on NYSE MKT. Price $7.55 (-1.05%), Market cap $0.09B, 52-week low–high $2.29 ~ $8.81.
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions,
Financial statements, price targets, institutional (13F) holdings and related news for Neuraxis, Inc. are updated in real time on BlackAll Trade.
Neuraxis, Inc. trades at $7.55 (-1.05%). Real-time quotes and charts are available on BlackAll Trade.
Neuraxis, Inc. has a market cap of about $0.09B.
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-S